O2 RegenTech

O2 RegenTech

O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary biopolymer technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote chronic wound healing.

Print
Claim My Business
View on Netcapital
Security Type
Common Stock
Min Investment
$102
Offering Date
November 08, 2023
Expected Close Date
January 27, 2024
Target Raise
$10.00K-$612.00K
Valuation
$6,800,000
Website
o2regentech.com
Amount Raised : $2,033
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment